Watanabe S, Fujita K.: Dietary Hyodeoxycholic Acid Exerts Hypolipidemic Effects by Reducing Farnesoid X Receptor Antagonist Bile Acids in Mouse Enterohepatic
Tissues. Lipids, 49:963-973, 2014

Watanabe　S., Fujita　K., Tsuneyama K., NoseM.: Changes in liver lipidomics associated with sodium cholate-induced liver injury and its prevention by boiogito, a Japanese herbal medicine, in mice. Trad Kampo Med, 3: 9-19, 2015.

Fujita K., Iguchi Y., Une M., Watanabe S.: Ursodeoxycholic acid suppresses lipogenesis in mouse liver: Possible role of the decrease in β-muricholic acid, a farnesoid X receptor antagonist. Lipids 52. 335-344, 2017.

Watanabe S., Fujita K., Nishida T., Imura J.: Ameliorative effect of animal bile preparations on dextran sulfate sodium-induced colitis in mice. Trad Kampo Med, 5: 67-74, 2018.

Watanabe　S., Chen Z., Fujita　K.:　Boiogito prevents dietary lithocholic acid (LCA)-induced cholestatic liver injury through the suppression of intestinal LCA absorption. Trad Kampo Med, 6, 71-78, 2019